Cardiovascular Biomarkers Deep Dive: Mike Lustgarten's 2025 Blood Test #7

Mike Lustgarten analyzes his personal cardiovascular disease biomarkers (lipid panel, lipoprotein(a), apoB, hsCRP) from blood test #7 in 2025, comparing results to literature-based optimal ranges rather than standard lab reference ranges.

Mike Lustgarten analyzes his personal cardiovascular disease biomarkers (lipid panel, lipoprotein(a), apoB, hsCRP) from blood test #7 in 2025, comparing results to literature-based optimal ranges rather than standard lab reference ranges. He demonstrates a self-tracking …

41 Early
Design 8
Sample 9
Peer Review 7
Replication 7
Transparency 10

NAD+ Biology and Aging: Expert Insights on Boosting NAD Levels

Dr.

Dr. Charles Brenner, a leading NAD researcher and discoverer of nicotinamide riboside, discusses why NAD levels matter for aging, exercise recovery, and disease prevention. He clarifies common misconceptions about NAD decline with age and explains …

64 Promising
Design 14
Sample 11
Peer Review 12
Replication 13
Transparency 14

Beta-2-Microglobulin and Neurogenesis: What's My Data?

Mike Lustgarten analyzes beta-2-microglobulin (B2M), a biomarker included in the Grimage epigenetic clock, exploring its role as a pro-aging factor that impairs neurogenesis in mice and is elevated in Alzheimer's disease brains.

Mike Lustgarten analyzes beta-2-microglobulin (B2M), a biomarker included in the Grimage epigenetic clock, exploring its role as a pro-aging factor that impairs neurogenesis in mice and is elevated in Alzheimer's disease brains. He presents his …

51 Promising
Design 11
Sample 9
Peer Review 11
Replication 8
Transparency 12

Oral Microbiome's Link to Alzheimer's Disease: New Research

Researchers from Lincoln Memorial University present evidence that oral microbiome imbalance (dysbiosis) may contribute to Alzheimer's disease through a pathway involving periodontal inflammation, cytokine release, and blood-brain barrier compromise.

Researchers from Lincoln Memorial University present evidence that oral microbiome imbalance (dysbiosis) may contribute to Alzheimer's disease through a pathway involving periodontal inflammation, cytokine release, and blood-brain barrier compromise. The oral cavity, being closer to …

43 Early
Design 11
Sample 6
Peer Review 11
Replication 7
Transparency 8